Medicine by its Russian trade name
Xarelto (Ксарелто) and alternatives in France
In France the medicine is sold under the same name, Xarelto. The active ingredient is rivaroxaban.
The direct anticoagulant rivaroxaban to prevent stroke in atrial fibrillation and treat thrombosis.
- Packages in the catalog
- 12 packages
- Forms
- Film-coated tablet, Granules for oral suspension
- Dispensing in France
- Prescription only
- Supply in France
- ANSM reports shortages for some packages
Forms and strengths in France
According to the official BDPM catalog. Packages declared as supplied to the French market come first. A manager confirms availability.
Alternatives to Xarelto: medicines with the same active ingredient
Medicines registered in France with the same active ingredients (rivaroxaban), according to the official BDPM catalog. Strengths, forms and excipients may differ; agree any substitution with your doctor.
- RIVAROXABAN ACCORDFilm-coated tablet · 10 mg, 15 mg, 20 mg
- RIVAROXABAN ALMUSFilm-coated tablet · 10 mg, 15 mg, 20 mg
- RIVAROXABAN ARROWFilm-coated tablet · 10 mg, 15 mg, 20 mg
- RIVAROXABAN BIOGARANFilm-coated tablet · 10 mg, 15 mg, 20 mg
- RIVAROXABAN CRISTERSFilm-coated tablet · 10 mg, 15 mg, 20 mg
- RIVAROXABAN EGFilm-coated tablet · 10 mg, 15 mg, 20 mg
- RIVAROXABAN EGHard capsule · 15 mg, 20 mg
- RIVAROXABAN EVOLUGENFilm-coated tablet · 10 mg, 15 mg, 20 mg
- RIVAROXABAN KRKAFilm-coated tablet · 10 mg, 15 mg, 20 mg
- RIVAROXABAN SANDOZFilm-coated tablet · 10 mg, 15 mg, 20 mg
- RIVAROXABAN TEVAFilm-coated tablet · 10 mg, 15 mg, 20 mg
- RIVAROXABAN VIATRISFilm-coated tablet · 2.5 mg, 10 mg, 15 mg, 20 mg
Showing 12 of 16. All medicines with rivaroxaban →
Active ingredient
Why Ксарелто may be missing from Russian pharmacies
A medicine can disappear from Russian pharmacies when its registration lapses or is suspended, the manufacturer leaves the market, supplies are interrupted or procurement changes. LekInfo does not track stock in Russian pharmacies: we show which forms and strengths are registered in France according to the official BDPM database and help you work it out in a consultation.
Prescription
In France Xarelto is a prescription-only medicine. Prescribing is a doctor’s decision; a manager will tell you which documents the consultation needs.
How to get a consultation about Xarelto
- 1. Find a medicine
Search by name, active ingredient or code. Information comes from BDPM, the official French medicines database.
- 2. Build a list
Add the medicines you have questions about to your consultation list and set the quantities.
- 3. Send a request
Choose how to reach you: email, Telegram, WhatsApp or phone. No account needed.
- 4. Get a manager’s reply
A manager will clarify the medicine details, check that they are current and explain the possible options. We usually reply within 2 hours during working hours.
Questions and answers
Where can I find Ксарелто if Russian pharmacies have none?
In France Xarelto is registered and listed in the official BDPM database: the catalog has 12 packages. Send a request to a manager, who will check that the information is current and explain the possible options. The consultation is free; we usually reply within 2 hours during working hours.
How much does Xarelto cost in France?
Reference guide: ≈ €30 – €83 per package depending on form and strength. This is BDPM reference data excluding delivery, not an offer to sell; a manager confirms the final terms.
What alternatives to Xarelto exist in France?
BDPM lists medicines with the same active ingredients (rivaroxaban): Xarelto, Rivaroxaban Accord, Rivaroxaban Almus and others. Strengths and forms may differ; agree any substitution with your doctor.
Is a prescription needed for Xarelto?
Yes, in France Xarelto is prescription-only. A manager will tell you which documents are needed.
Is Xarelto the same as Ксарелто?
Yes, it is the same medicine under the same name; the active ingredient is rivaroxaban. Strengths and forms in France may differ from Russian ones, so check them against your prescription.
This is reference information, not advertising or an offer to sell, and it does not replace a doctor’s advice. Source: BDPM, the official French medicines database (ANSM), catalog version of 3 November 2026.